IVD
The Chikungunya IgM/IgG Rapid Test is a fast and reliable diagnostic tool for detecting antibodies to the Chikungunya virus in human serum, plasma, or whole blood. Using advanced lateral flow immunoassay technology, this chikungunya fever test identifies both IgM and IgG antibodies within 15 minutes, making it ideal for early screening and clinical diagnosis.
Designed with recombinant antigens from Chikungunya structural proteins, the test ensures high sensitivity and specificity. It requires no specialized laboratory equipment, allowing healthcare providers, clinics, and even field workers to perform the test with ease. As a result, it serves as an essential point-of-care solution for the rapid detection and management of Chikungunya infections. The chikungunya test price is cheaper than other tests on the market.
Chikungunya Lab IgG/lgM Antibody Fever Rapid Test
- Key Features: High precision, easy-to-read results, user-friendly and safe
- Sample Type: Whole blood, serum, or plasma
- Test Duration: 15 minutes
- Shelf Life: 2 years
- Storage Conditions: 2–30 °C
- Clinical Performance: Sensitivity – IgM: 95.96%, IgG: 96.08%; Specificity – IgM: 99.17%, IgG: 99.26%
- Application: Certification organizations, clinics, CDC, hospitals, home self-testing
How the Chikungunya IgG/IgM Rapid Test Works?
The Chikungunya lab IgG/IgM antigen antibody Rapid Test is a fast and reliable point-of-care diagnostic tool that uses lateral flow immunoassay technology to detect IgG and IgM antibodies to the Chikungunya virus in human blood, serum, or plasma. The test incorporates gold-labeled mouse anti-human IgG/IgM antibodies combined with recombinant Chikungunya antigens on a conjugate pad. When a sample is added, any target antibodies present bind to these antigen-gold complexes and migrate along a nitrocellulose membrane containing capture lines for IgG, IgM, and a control. Positive reactions produce visible lines within 15 minutes, allowing rapid confirmation of infection without specialized laboratory equipment or extensive training. This quick and easy visual readout supports timely diagnosis and clinical decisions, even in field settings or during outbreaks.
Which tests are done for chikungunya?
Chikungunya infection can be diagnosed using serological tests, such as IgM/IgG rapid tests and ELISA, which detect antibodies against the virus. However, these tests typically become positive several days after symptom onset. In contrast, molecular tests such as RT-PCR, which identify viral RNA, are most effective in the early phase of infection, typically within the first week. Furthermore, rapid antibody tests are commonly used for quick screening at clinics and point-of-care settings, while PCR provides accurate confirmation during the early stages.
